Intelligence / Healthtech / New Clinical Trials / Eli Lilly and Company
Clinicaltrial registered4 Nov 2026
Eli Lilly and Company
4 Nov 2026: Trial registered · A Study of Lepodisiran (LY3819469) in Participants With High Lipoprotein(a). Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 4 Nov 2026
- Title
- A Study of Lepodisiran (LY3819469) in Participants With High Lipoprotein(a)
- Conditions
- Lipoprotein(a)
- Phase
- Phase 1
- Study Type
- Interventional
- Status
- Recruiting
- Countries
- Singapore
- Country
- Singapore
- Reference
- NCT07914738
- Location
- Singapore
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Eli Lilly and Company
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Across AOS Research
Other records for Eli Lilly and Company in our registers.
18 NovEli Lilly and Companytrial registered · HealthtechClinical17 NovEli Lilly and Companytrial registered · HealthtechClinical13 NovEli Lilly and Companytrial registered · HealthtechClinical13 NovEli Lilly and Companytrial registered · HealthtechClinical10 NovEli Lilly and Companytrial registered · HealthtechClinical10 NovEli Lilly and Companytrial registered · HealthtechClinical10 NovEli Lilly and Companytrial registered · HealthtechClinical6 NovEli Lilly and Companytrial registered · HealthtechClinical5 NovEli Lilly and Companytrial registered · HealthtechClinical4 NovEli Lilly and Companytrial registered · HealthtechClinical28 OctEli Lilly and Companytrial registered · HealthtechClinical22 OctEli Lilly and Companytrial registered · HealthtechClinical
More from Singapore
New Clinical Trials
17 NovAstraZenecatrial registered · A Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLCClinical13 NovEli Lilly and Companytrial registered · A Study Assessing Eloralintide (LY3841136) in Healthy ParticipantsClinical12 NovHALEONtrial registered · A Retrospective Study to Assess Patient-Reported Treatment Experience With Over-the-Counter Analgesic ProductsClinical5 NovCutis Medical Laser Clinics Pte Ltdtrial registered · Effectiveness of Sequential Monopolar and Bipolar Radiofrequency Device for Facial Rejuvenation in Female ParticipantsClinical4 NovBoehringer Ingelheimtrial registered · A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Clinical4 NovEli Lilly and Companytrial registered · A Study of LY4247147 in Participants With Obesity or Overweight Who Are Otherwise HealthyClinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.